Explainable AI-based analysis of human pancreas sections identifies traits of type 2 diabetes

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Lukas Klein - , German Cancer Research Center (DKFZ), ETH Zurich, Swiss Federal Institute of Technology Lausanne (EPFL) (Author)
  • Sebastian Ziegler - , German Cancer Research Center (DKFZ) (Author)
  • Felicia Gerst - , University of Tübingen, University Hospital Tübingen, German Center for Diabetes Research (DZD) (Author)
  • Yanni Morgenroth - , Molecular Diabetology, German Center for Diabetes Research (DZD), University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Karol Gotkowski - , German Cancer Research Center (DKFZ) (Author)
  • Eyke Schöniger - , German Center for Diabetes Research (DZD), Molecular Diabetology, University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Martin Heni - , Ulm University, University Hospital Tübingen (Author)
  • Nicole Kipke - , German Center for Diabetes Research (DZD), University Hospital Carl Gustav Carus Dresden, Molecular Diabetology, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich, Department of Visceral, Thoracic and Vascular Surgery (Author)
  • Daniela Friedland - , German Center for Diabetes Research (DZD), Molecular Diabetology, University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Annika Seiler - , German Center for Diabetes Research (DZD), Molecular Diabetology, University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Ellen Geibelt - , Center for Molecular and Cellular Bioengineering (CMBC) (Author)
  • Hajime Yamazaki - , Kyoto University, Fukushima Medical University (Author)
  • Hans Ulrich Häring - , University of Tübingen, University Hospital Tübingen, German Center for Diabetes Research (DZD) (Author)
  • Silvia Wagner - , University Hospital Tübingen (Author)
  • Silvio Nadalin - , University Hospital Tübingen (Author)
  • Alfred Königsrainer - , University Hospital Tübingen (Author)
  • Andre L. Mihaljevic - , University Hospital Tübingen (Author)
  • Daniel Hartmann - , University Hospital Tübingen (Author)
  • Falko Fend - , University Hospital Tübingen (Author)
  • Daniela Aust - , Institute of Pathology, University Hospital Carl Gustav Carus Dresden (Author)
  • Jürgen Weitz - , Department of Visceral, Thoracic and Vascular Surgery, German Center for Diabetes Research (DZD), University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Reiner Jumpertz-von Schwartzenberg - , University of Tübingen, University Hospital Tübingen, German Center for Diabetes Research (DZD) (Author)
  • Marius Distler - , Department of Visceral, Thoracic and Vascular Surgery, German Center for Diabetes Research (DZD), University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Klaus Maier-Hein - , German Cancer Research Center (DKFZ), Heidelberg University  (Author)
  • Andreas L. Birkenfeld - , University of Tübingen, University Hospital Tübingen, German Center for Diabetes Research (DZD) (Author)
  • Susanne Ullrich - , University of Tübingen, University Hospital Tübingen, German Center for Diabetes Research (DZD) (Author)
  • Paul F. Jäger - , German Cancer Research Center (DKFZ) (Author)
  • Fabian Isensee - , German Cancer Research Center (DKFZ) (Author)
  • Michele Solimena - , Molecular Diabetology, German Center for Diabetes Research (DZD), University Hospital Carl Gustav Carus Dresden, Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich (Author)
  • Robert Wagner - , German Center for Diabetes Research (DZD), University Hospital Duesseldorf, German Diabetes Center Düsseldorf (Author)

Abstract

Type 2 diabetes (T2D) is a chronic disease currently affecting around 500 million people worldwide with often severe health consequences. Yet, histopathological analyses are still inadequate to infer the glycaemic state of a person based on morphological alterations linked to impaired insulin secretion and β-cell failure in T2D. Giga-pixel microscopy can capture subtle morphological changes, but data complexity exceeds human analysis capabilities. In response, we generate a dataset of pancreas whole-slide images from living donors with multiple chromogenic and multiplex immunofluorescence stainings and train deep learning models to predict the T2D status. Using explainable AI, we make the learned relationships interpretable, quantify them as biomarkers, and assess their association with T2D. Remarkably, the highest prediction performance is achieved by simultaneously focusing on islet α- and δ-cells and neuronal axons, alongside subtle pancreatic alterations in T2D donors such as larger adipocyte clusters, altered islet-adipocyte proximity and smaller islets. This data-driven approach provides a foundation for future research into relevant diagnostic and therapeutic targets, refining several hypotheses regarding tissue alterations associated with T2D.

Details

Original languageEnglish
Article number1558
Number of pages17
JournalNature communications
Volume17
Issue number1
Publication statusPublished - 9 Feb 2026
Peer-reviewedYes

External IDs

PubMed 41663377